Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results

Ake Hjalmarson

Gordon Tomaselli
N Engl J Med 2007;357
AKE HJALMARSON, Sahlgrenska University, Göteborg
COMMENT: GORDON TOMASELLI, Johns Hopkins University, Baltimore
The lipid